tiprankstipranks
Trending News
More News >
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market

Kairos Pharma, Ltd. (KAPA) Income Statement

Compare
128 Followers

Kairos Pharma, Ltd. Income Statement

Last quarter (Q3 2025), Kairos Pharma, Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kairos Pharma, Ltd.'s net income was $-1.40M. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -160.00K$ -160.00K$ -160.00K$ -98.00K$ 0.00
Operating Expenses
$ 2.18M$ 1.55M$ 411.00K$ 1.84M$ 1.05M
Depreciation and Amortization
$ 160.00K$ 160.00K$ 160.00K$ 98.00K$ 0.00
EBITDA
$ -1.58M$ -1.55M$ -411.00K$ -1.84M$ -1.05M
Operating Income
$ -2.34M$ -1.71M$ -571.00K$ -1.94M$ -1.05M
Other Income/Expenses
$ -260.00K$ -98.00K$ -479.00K$ -202.00K-
Pretax Income
$ -2.60M$ -1.81M$ -1.05M$ -2.15M$ -1.05M
Net Income
$ -2.60M$ -1.81M$ -1.05M$ -2.15M$ -1.05M
Per Share Metrics
Basic EPS
$ -0.23$ -0.17$ -0.10$ -0.17$ -0.09
Diluted EPS
$ -0.23$ -0.17$ -0.10$ -0.17$ -0.09
Weighted Average Shares Outstanding
11.36M 10.38M 10.24M 12.84M 11.22M
Weighted Average Shares Outstanding (Diluted)
11.36M 10.38M 10.24M 12.84M 11.22M
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History